Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma.
about
Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer PatientsInfluence of VEGFR single nucleotide polymorphisms on the efficacy of sunitinib therapy against renal cell carcinoma.Genetic polymorphisms of CYP3A4 among Chinese patients with steroid-induced osteonecrosis of the femoral head.Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma.Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma.Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
P2860
Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Sunitinib-induced hypertension ...... tastatic renal cell carcinoma.
@en
Sunitinib-induced hypertension ...... tastatic renal cell carcinoma.
@nl
type
label
Sunitinib-induced hypertension ...... tastatic renal cell carcinoma.
@en
Sunitinib-induced hypertension ...... tastatic renal cell carcinoma.
@nl
prefLabel
Sunitinib-induced hypertension ...... tastatic renal cell carcinoma.
@en
Sunitinib-induced hypertension ...... tastatic renal cell carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Sunitinib-induced hypertension ...... etastatic renal cell carcinoma
@en
P2093
A Belaustegui
D Castellano
H Gelderblom
R H Mathijssen
P2860
P2888
P356
10.1038/TPJ.2015.100
P577
2016-01-26T00:00:00Z
P5875
P6179
1023932149